
TY  - JOUR
TI  - RHEUMATOID ARTHRITIS – AETIOLOGY AND PATHOGENESIS/ANIMAL MODEL
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_25.x
DO  - doi:10.1111/j.1479-8077.2006.00199_25.x
SP  - A211
EP  - A225
PY  - 2006
ER  - 

TY  - JOUR
TI  - SYSTEMIC LUPUS ERYTHEMATOSUS – AETIOLOGY AND PATHOGENESIS/ANIMAL MODELS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_29.x
DO  - doi:10.1111/j.1479-8077.2006.00199_29.x
SP  - A247
EP  - A253
PY  - 2006
ER  - 

TY  - JOUR
TI  - CARTILAGE IN BONE BIOLOGY AND PATHOPHYSIOLOGY
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_5.x
DO  - doi:10.1111/j.1479-8077.2006.00199_5.x
SP  - A33
EP  - A39
PY  - 2006
ER  - 

TY  - JOUR
TI  - ALLIED HEALTH PROFESSIONALS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_1.x
DO  - doi:10.1111/j.1479-8077.2006.00199_1.x
SP  - A21
EP  - A25
PY  - 2006
ER  - 

TY  - JOUR
TI  - EPIDEMIOLOGY OF RHEUMATIC DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_10.x
DO  - doi:10.1111/j.1479-8077.2006.00199_10.x
SP  - A54
EP  - A66
PY  - 2006
ER  - 

TY  - JOUR
TI  - SCLERODERMA AND RELATED SYNDROMES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_26.x
DO  - doi:10.1111/j.1479-8077.2006.00199_26.x
SP  - A225
EP  - A230
PY  - 2006
ER  - 

TY  - JOUR
TI  - DIAGNOSTICS AND IMAGING PROCEDURES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_8.x
DO  - doi:10.1111/j.1479-8077.2006.00199_8.x
SP  - A45
EP  - A51
PY  - 2006
ER  - 

TY  - JOUR
TI  - EDUCATION
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_9.x
DO  - doi:10.1111/j.1479-8077.2006.00199_9.x
SP  - A52
EP  - A54
PY  - 2006
ER  - 

TY  - JOUR
TI  - Posters 01–110
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 90
IS  - S1
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.4263
DO  - doi:10.1002/bjs.4263
SP  - 105
EP  - 150
PY  - 2003
ER  - 

AU  - Nehoff, Hayley
AU  - Parayath, Neha N.
AU  - Taurin, Sebastien
AU  - Greish, Khaled
C7  - pp. 65-86
TI  - In Vivo Evaluation of Acute and Chronic Nanotoxicity
SN  - 9781118439265
UR  - https://doi.org/10.1002/9781118856017.ch3
DO  - doi:10.1002/9781118856017.ch3
SP  - 65-86
KW  - nanotechnology
KW  - nanomedicine
KW  - pseudoallergy
KW  - acute toxicity
KW  - chronic toxicity
KW  - subchronic toxicity
KW  - thrombosis
KW  - nanoparticle
KW  - mesothelioma
KW  - route of exposure
PY  - 2003
AB  - Summary Nanotechnology is becoming increasingly important in a variety of fields ranging from medicine to textiles, and their concentration is building up gradually in our ecosystem. Consequently, the risk of being exposed to nanomaterials has significantly increased. Toxicity testing is essential to properly understand and manage the risks associated with exposure to nanomaterials, whether for the approval of a nanoconstructs' medical use or in the interests of public safety. Although in vitro methods of testing are advancing, they cannot yet replace the need for in vivo testing because of their limitations in modeling certain parameters of nanoparticles such as a biodistribution, metabolism, and organ specific toxicity. This chapter outlines the importance of nanomaterial composition and exposure route on the resulting toxicity. We also provide guidelines for appropriate tests to be utilized when examining in vivo nanotoxicity.
ER  - 

TY  - JOUR
TI  - 2014 ACR/ARHP Annual Meeting Abstract Supplement
JO  - Arthritis & Rheumatology
JA  - Arthritis & Rheumatology
VL  - 66
IS  - S10
SN  - 9781118439265
UR  - https://doi.org/10.1002/art.38914
DO  - doi:10.1002/art.38914
SP  - S1
EP  - S1402
PY  - 2014
AB  - For a searchable version of these abstracts, please visit www.acrabstracts.org.
ER  - 

TY  - JOUR
TI  - Abstracts of the Third International Congress. Psoriasis: From Gene to Clinic
JO  - British Journal of Dermatology
VL  - 147
IS  - 5
SN  - 9781118439265
UR  - https://doi.org/10.1046/j.1365-2133.2002.05072.x
DO  - doi:10.1046/j.1365-2133.2002.05072.x
SP  - 1047
EP  - 1078
PY  - 2002
ER  - 

TY  - JOUR
TI  - Poster Session II
JO  - Bipolar Disorders
JA  - Bipolar Disord
VL  - 15
IS  - s1
SN  - 9781118439265
UR  - https://doi.org/10.1111/bdi.12084
DO  - doi:10.1111/bdi.12084
SP  - 104
EP  - 155
PY  - 2013
ER  - 

AU  - Geboes, Karel
C7  - pp. 315-372
TI  - Inflammatory Disorders of the Small Intestine
SN  - 9781405199438
UR  - https://doi.org/10.1002/9781118399668.ch20
DO  - doi:10.1002/9781118399668.ch20
SP  - 315-372
KW  - virus
KW  - bacteria
KW  - helminths
KW  - protozoa
KW  - AIDS
KW  - Whipple's disease
KW  - Crohn's disease
KW  - ulcerative colitis
KW  - pouchitis
KW  - drugs
KW  - eosinophils
KW  - ulceration
PY  - 2013
AB  - Summary Inflammation of the small intestine is common worldwide. Infections are the major cause whereas chronic inflammatory bowel diseases (CIBD), drugs and other conditions are less frequent causes. Worldwide, enteric infections rank third among all causes of disease burden. The main infectious agents include a variety of viruses and bacterial agents. As endoscopy is used more frequently, the pathologist is more likely to see small intestinal biopsies for the diagnosis of inflammatory lesions, although histology most often does not contribute much to the specific diagnosis of infections. Histology is, however, very important in chronic conditions, allowing the identification of pathogens, such as cytomegalovirus, and the differential diagnosis between CIBD and drug- or infection-related conditions, such as tuberculosis, based on the morphology of the lesions. Histological analysis is equally important for the diagnosis of inflammation in patients with a disturbed immune system, such as transplant recipients and for the identification of rare diseases.
ER  - 

TY  - JOUR
TI  - COLON AND RECTAL SURGERY
JO  - ANZ Journal of Surgery
VL  - 76
IS  - s1
SN  - 9781405199438
UR  - https://doi.org/10.1111/j.1445-2197.2006.03806.x
DO  - doi:10.1111/j.1445-2197.2006.03806.x
SP  - A14
EP  - A21
PY  - 2006
ER  - 

TY  - JOUR
TI  - 3rd Meeting of the French Pharmacological Society Nantes, France, 15–17 March 1999
JO  - Fundamental & Clinical Pharmacology
VL  - 13
IS  - 3
SN  - 9781405199438
UR  - https://doi.org/10.1111/j.1472-8206.1999.tb00354.x
DO  - doi:10.1111/j.1472-8206.1999.tb00354.x
SP  - 343
EP  - 435
PY  - 1999
ER  - 

TY  - JOUR
TI  - Abstract Index
JO  - Journal of Gastroenterology and Hepatology
VL  - 19
IS  - s7
SN  - 9781405199438
UR  - https://doi.org/10.1111/j.1440-1746.2004.03735.x
DO  - doi:10.1111/j.1440-1746.2004.03735.x
SP  - A676
EP  - A868
PY  - 2004
ER  - 

TY  - JOUR
AU  - Sander, Miriam
AU  - Trump, Benjamin F.
AU  - Harris, Curtis C.
TI  - The 23rd Aspen Cancer Conference: Mechanisms of toxicity, carcinogenesis, cancer prevention and cancer therapy 2008
JO  - Molecular Carcinogenesis
JA  - Mol. Carcinog.
VL  - 48
IS  - 5
SN  - 9781405199438
UR  - https://doi.org/10.1002/mc.20493
DO  - doi:10.1002/mc.20493
SP  - 465
EP  - 478
PY  - 2009
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Colorectal Disease
VL  - 4
IS  - s1
SN  - 9781405199438
UR  - https://doi.org/10.1046/j.1463-1318.4.s1.6.x
DO  - doi:10.1046/j.1463-1318.4.s1.6.x
SP  - 1
EP  - 39
PY  - 2002
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Neurogastroenterology & Motility
VL  - 21
IS  - s1
SN  - 9781405199438
UR  - https://doi.org/10.1111/j.1365-2982.2009.01343_2.x
DO  - doi:10.1111/j.1365-2982.2009.01343_2.x
SP  - 15
EP  - 98
PY  - 2009
ER  - 
